OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024More prescriptions filled through February ...

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers wit ...

The NHS is urging thousands of people to cut down on their intake of tea and coffee due to an uncomfortable side effect ...

Phase 1 healthy volunteer trial ongoing, complete SAD/MAD data expected in June 2025KT-621 Phase 1b trial in atopic dermatitis ...

Thousands of people in the UK who take the medication are being encouraged to make the diet change to avoid side effects ...

Steven Sell; President, Chief Executive Officer, Director; agilon health inc Jeffrey Schwaneke; Chief Financial Officer, Executive Vice President; agilon health inc Thank you, operator. Good afternoon ...

Q4 2024 Earnings Call Transcript February 26, 2025 Operator: Hello and welcome to the agilon health Fourth Quarter 2024 ...

Aerosol Delivery Devices Market Research Report In 2019, the aerosol delivery devices market is projected to reach $46.73 billion by 2027, ...

Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

Pope Francis was in pain, swollen and walking very little. Italian pulmonologist Dr. Barbara Moscatelli says that this is ...

Astrana Health, Inc. ( NASDAQ: ASTH) Q4 2024 Earnings Conference Call February 27, 2025 5:30 PM ET Brandon Sim - President & CEO Chan Basho - Chief Operating & Financial Officer ...